EC Inwald

902 total citations · 1 hit paper
11 papers, 517 citations indexed

About

EC Inwald is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, EC Inwald has authored 11 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in EC Inwald's work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer survivorship and care (3 papers). EC Inwald is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer survivorship and care (3 papers). EC Inwald collaborates with scholars based in Germany, Austria and Netherlands. EC Inwald's co-authors include Olaf Ortmann, Ferdinand Hofstädter, Monika Klinkhammer‐Schalke, Michael Koller, Florian Zeman, M Gerstenhauer, Matthias Evert, Gero Brockhoff, Simone Wesselmann and Stefanie Buchholz and has published in prestigious journals such as Annals of Oncology, BioMed Research International and Breast Cancer Research and Treatment.

In The Last Decade

EC Inwald

10 papers receiving 507 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

2013 434 citations EC Inwald, Monika Klinkhammer‐Schalke et al. Breast Cancer Research and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
EC Inwald Germany	6	266	260	114	109	98	11	517
M Gerstenhauer Germany	7	262 1.0×	259 1.0×	122 1.1×	108 1.0×	93 0.9×	7	609
Monica Jernberg Engstrøm Norway	11	273 1.0×	242 0.9×	147 1.3×	79 0.7×	72 0.7×	21	472
Nirmala Pathmanathan Australia	14	245 0.9×	273 1.1×	126 1.1×	152 1.4×	63 0.6×	40	553
Ivana Božović‐Spasojević Serbia	8	299 1.1×	259 1.0×	159 1.4×	61 0.6×	111 1.1×	17	501
Zhimin Shao China	11	316 1.2×	234 0.9×	233 2.0×	78 0.7×	89 0.9×	20	592
Saskia van de Ven Netherlands	8	242 0.9×	193 0.7×	63 0.6×	68 0.6×	58 0.6×	14	361
Jessica Young United States	12	270 1.0×	331 1.3×	243 2.1×	85 0.8×	159 1.6×	29	652
Rebekah Gould United States	7	447 1.7×	497 1.9×	130 1.1×	177 1.6×	98 1.0×	13	721
Yoshiaki Sagara Japan	14	356 1.3×	221 0.8×	122 1.1×	97 0.9×	120 1.2×	31	639
Hong Ling China	16	240 0.9×	187 0.7×	190 1.7×	83 0.8×	80 0.8×	33	583

Countries citing papers authored by EC Inwald

Since Specialization

Citations

This map shows the geographic impact of EC Inwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EC Inwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EC Inwald more than expected).

Fields of papers citing papers by EC Inwald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by EC Inwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EC Inwald. The network helps show where EC Inwald may publish in the future.

Co-authorship network of co-authors of EC Inwald

This figure shows the co-authorship network connecting the top 25 collaborators of EC Inwald. A scholar is included among the top collaborators of EC Inwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with EC Inwald. EC Inwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bjelic‐Radisic, Vesna, Fátima Cardoso, Joachim Weis, et al.. (2024). 270MO An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: Results of the validation study phase IV EORTC QLQ-BR42. ESMO Open. 9. 103329–103329. 1 indexed citations

Ortmann, Olaf, et al.. (2022). Does cavity margin shaving reduce residual tumor and re‐excision rates? A systematic review. Archives of Gynecology and Obstetrics. 307(4). 1295–1309. 1 indexed citations

Inwald, EC, Christoph Kowalski, Simone Wesselmann, Julia Ferencz, & Olaf Ortmann. (2019). Recommendation of adjuvant trastuzumab treatment in HER-2-positive breast cancer patients: insights from quality indicator data collected in certified breast cancer centers in Germany, Italy, Austria, and Switzerland. Archives of Gynecology and Obstetrics. 300(2). 383–388. 5 indexed citations

Bjelic‐Radisic, Vesna, Andrew Bottomley, Fátima Cardoso, et al.. (2018). An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45. Annals of Oncology. 29. viii59–viii60. 5 indexed citations

Inwald, EC, Olaf Ortmann, Michael Koller, et al.. (2017). Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Research and Treatment. 163(1). 119–130. 26 indexed citations

Inwald, EC, et al.. (2016). Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma. Archives of Gynecology and Obstetrics. 294(4). 825–831. 6 indexed citations

Inwald, EC, Michael Koller, Monika Klinkhammer‐Schalke, et al.. (2015). Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry. Journal of Cancer Research and Clinical Oncology. 141(12). 2229–2240. 10 indexed citations

Inwald, EC, Monika Klinkhammer‐Schalke, Michael Koller, & Olaf Ortmann. (2014). Quality Assurance for Patients with Breast Cancer – the Impact of Clinical Cancer Registries. Geburtshilfe und Frauenheilkunde. 74(9). 868–874.

Klinkhammer‐Schalke, Monika, Michael Koller, Olaf Ortmann, et al.. (2014). Patientenwohl. Lebensqualität bei Brustkrebs-Patientinnen – Implementierung und Umsetzung in die Routineversorgung. Geburtshilfe und Frauenheilkunde. 74(6). 531–534. 1 indexed citations

10.

Inwald, EC, Olaf Ortmann, Florian Zeman, et al.. (2014). Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry. BioMed Research International. 2014. 1–10. 28 indexed citations

11.

Inwald, EC, Monika Klinkhammer‐Schalke, Ferdinand Hofstädter, et al.. (2013). Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Research and Treatment. 139(2). 539–552. 434 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact